Daikenchuto (TU‐100) shapes gut microbiota architecture and increases the production of ginsenoside metabolite compound K

Daikenchuto (TU‐100) shapes gut microbiota architecture and increases the production of ginsenoside metabolite compound K

Many pharmaceutical agents not only require microbial metabolism for increased bioavailability and bioactivity, but also have direct effects on gut microbial assemblage and function. We examined the possibility that these actions are not mutually exclusive and may be mutually reinforcing in ways tha...

Full description

Bibliographic Details
Main Authors: Hasebe, Takumu, Ueno, Nobuhiro, Musch, Mark W., Nadimpalli, Anuradha, Kaneko, Atsushi, Kaifuchi, Noriko, Watanabe, Junko, Yamamoto, Masahiro, Kono, Toru, Inaba, Yuhei, Fujiya, Mikihiro, Kohgo, Yutaka, Chang, Eugene B.
Format: Online
Language:English
Published: John Wiley and Sons Inc. 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777267/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777267/

Similar Items